Helpline 07939 046 030

Postponed: Medicine and Me: Living with Nerve Tumours at the Royal Society of Medicine

13 March 2020

We would like to update you regarding the Medicine and Me: Living with nerve tumours event that was due to take place at the Royal Society of Medicine on Thursday 23 April 2020. Unfortunately due to the current Coronavirus (COVID19) situation and the lockdown restrictions in place, The Royal Soceity of Medicine has decided to cancel any in person events taking place in July 2020.

As such the Medicine and Me: Living with nerve tumours meeting due to take place on Monday 13 July 2020 has now been postponed. Currently there is not a new date set, however this will most likely be in early 2021. The Royal Society of Medicine will be in contact with ticket holders directly in due course and tickets will be valid for the to be agreed later date. We will keep you posted on any further developments.

 

Medicine and Me: Living with Nerve Tumours

Postponed until further notice 
The Royal Society of Medicine
1 Wimpole Street, London

Nerve Tumours UK and The Royal Society of Medicine invite you to attend a half day conference highlighting and discussing Neurofibromatosis.

The country's leading experts in Neurofibromatosis Type 1 and Type 2 will review and discuss current approaches to diagnosis and treatment, in the light of advances in molecular biology and imaging. There will be patient presentations and a panel discussion.

By attending this meeting, you will have the opportunity to:

  • Understand the epidemiology, biology and genetics of Nerve Tumours - Neurofibromatosis I (NF1) and Neurofibromatosis 2 (NF2)
  • Appreciate the impact of living with NF1 and NF2 first-hand from patients 
  • Learn about the recognition of malignant transformation (NF1)
  • Discover the management of NF2 nerve tumours
  • Explore today’s treatments
  • Understand the management and support for people with Neurofibromatosis

 About Medicine and Me

Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management.

Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.

The Programme and tickets, free of charge for patients, carers, relatives, students and trainees are available on the link below: 

BSL Translators will be in attendance, and for any further special access or specific needs, please email us at info@nervetumours.org.uk by 31 March 2020

Filter News

Filter by Date
Category
Reset

“Happy Easter”

A message from Karen, our Charity Director, wishing you a very Happy Easter!

Read More

Lisa helps Shine a Light on Neurofibromatosis in Belfast

Lisa has NF1, & lobbied the Belfast Lord Mayor to get Belfast City Hall lit up blue on Neurofibromatosis Day, 17th May

Read More

Alex’s NF1 story

Alex describes her life with NF1, growing up in care, doing adaptive boxing & gym classes & getting NCFE Care qualifications

Read More

Sumeeth’s Schwannoma story

Sumeeth, thought nothing of a muscle twitch after a hangover - it was the first symptom that led to a Schwannoma diagnosis

Read More

Laura’s NF1 story

Laura is doing a skydive fundraiser to raise awareness & funds for NTUK, after her daughter was diagnosed with NF1

Read More

Kian’s NF2 Blog

Kian shares his NF2 journey and his inspirational path - training to swim in the para-olympics

Read More

Disfigurement equality at work - research

This research study by Queen Mary University, London, aims to improve workplace equality for people with disfigurements

Read More

RAISING THE ROOF: CHARITY COMEDY NIGHT IN AID OF NERVE TUMOURS UK

Join us in London on our first comedy night to celebrate 40 years of Nerve Tumours UK

Read More

NF1 stem cell research study

Julieta is carrying out stem cell research to understand brain development in those with NF1

Read More